A Short Overview of Curcuma aeruginosa with Curative Potentials Against COVID-19

Swandari Paramita1,2,*,, Sjarif Ismail1,3, Emil Bachtiar Moerad4 and Eva Marliana1,5

1Research Center of Natural Products from Tropical Rainforest (PUI-PT OKTAL), Mulawarman University, Samarinda, Indonesia

2Department of Community Medicine, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia

3Department of Pharmacology, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia

4Department of Pulmonology, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia

5Department of Chemistry, Faculty of Mathematics and Natural Sciences, Mulawarman University, Samarinda, Indonesia

*Corresponding author: E-mail: s.paramita@fk.unmul.ac.id

Abstract

COVID-19 (coronavirus disease) is an infectious disease of the respiratory tract caused by SARS-CoV-2. Nature has provided a great source of antiviral compounds, from which innovative products for the treatment of COVID-19 can be produced. One of the medicinal plants that can be developed for the treatment of COVID-19 is Curcuma aeruginosa Roxb. Previous studies have found tracheospasmolytic and anti-inflammatory activity of this indigenous Curcuma species. There are 10 chemical compounds from Curcuma aeruginosa that have been proven against COVID-19, namely 1,8-cineole (eucalyptol), α-terpineol, β-caryophyllene, β-eudesmol, β-pinene, β-sitosterol, curcumenol, palmitic acid, succinic acid and zingiberene. Further research is needed for C. aeruginosa to become a new antiviral drug for the treatment of COVID-19.

Keywords

Curcuma aeruginosa, Chemical compounds, COVID-19.

   View Article PDF File Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.